MEDIROM Healthcare Technologies
MRM
2 hedge funds and large institutions have $323 invested in MEDIROM Healthcare Technologies in 2023 Q3 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, reducing their positions, and 0 closing their positions.
0% more ownership
Funds ownership: 0% → 0% (+0%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$292 |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$35 |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Bank of America
Charlotte,
North Carolina
| $289 | +$292 | +50 | New |
|
|
TRCT
2
Tower Research Capital (TRC)
New York
| $34 | +$35 | +6 | New |
|
MRM Hedge Fund Activity: Q3 2023 in Review
2 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in MEDIROM Healthcare Technologies (MRM) for Q3 2023, worth a combined $323.
Buyers outnumbered sellers: 2 funds opened new MRM positions and 0 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Bank of America, opening a new position worth an estimated $292.
- 2 institutional investors held MEDIROM Healthcare Technologies (MRM) as of Q3 2023, up from 0 in Q2 2023.
- Funds reported $323 of MEDIROM Healthcare Technologies stock for Q3 2023.
- 2 funds opened new MEDIROM Healthcare Technologies positions in Q3 2023 and 0 closed out, a net change of +2 holders.
- The largest MEDIROM Healthcare Technologies buyer in Q3 2023 was Bank of America, an estimated $292 added.
Based on aggregated 13F filings for Q3 2023.